Comparison of efficiency of cardiogoniometry and ergometry in diagnostics of stable coronary artery disease in wome

Not Applicable

• Conditions: I20; I20.1; I20.8; I20.9; Angina pectoris; Angina pectoris with documented spasm; Other forms of angina pectoris; Angina pectoris, unspecified

• Registration Number: DRKS00006119
• Lead Sponsor: niversitiy Hospital Centre Sisters of Charity

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2014-04-29
• Study Completion: 2015-05-15
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 114

Inclusion Criteria

Inclusion Criteria: women between 18-85 years old who have clinical symptoms of stabile angina pectoris (stenocardia or dyspnea in physical exertion) and are able to understand and sign informed consent.

Exclusion Criteria

Exclusion Criteria:
1.Patients with symptoms of unstable angina pectoris (stenocardia or chest pain/pressure at rest or in minimal physical activity
2.Patients with known coronary artery disease with or without implantated coronary stents
3.Patients with suffered myocardial infarction (STEMI, NSTEMI),
4.Patients with left bundle branch block,
5.Patients with implantated perenent cardiac pacemaker or ICD,
6.Patients that underwent the cardiothoracic myocardial revascularisation with coronary artery by-pass graft (CABG) and/or replacement of one or more cardiac valves
7.Patients with congenital cardiac anomaly (corrected or not)
8.Patients with dysfunction of one or more cardiac valves of moderate to severe stage, or left ventricular aneurysm (all proved with echocardiography)
9.Patients with chronic renal insufficiency of = III stage
10.Pregnant women
11.Patients with chronic obstructive pulmonary disease (COPD)
12.Patients with life-expectance less than 12 months
13.Patients with anaemia (haemoglobin < 100 g/L)
14.Patients with history of alcohol and/or drug abuse
15.Patients who are involved in another clinical trial
16.Patients who are, regarding their behaviour, not expected to accomplish this trial (compliance, impossibility for coronarography to be done in our center)
17.Patients with emergency clinical status during the hospitalization (no matter the cause)
18.Patients with no signed informed consent

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Efficiency (sensitivity and specificity) of cardiogoniometry in diagnostics of coronary artery disease (CAD) in women with stabile angina pectoris<br><br>In every woman with clinical symptoms of angina pectoris and suspected CAD, undergoing coronary angiography, the cardiogoniometry will be done. The coronary angiography is the invasive method for determining the presence of significant CAD. The results of cardiogoniometry, which is a non-invasive diagnostic method, will be compared with results of coronary angiographies in every individual female patient.

Secondary Outcome Measures

Name	Time	Method
Comparison of cardiogoniometry’s efficiency with the one of ergometry, in detecting CAD in women with clinical angina pectoris